Northland Securities Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $9
Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Milestone Pharmaceuticals (MIST) and Personalis (PSNL)
Heron Therapeutics Analyst Ratings
Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $4
Analysts' Top Healthcare Picks: Heron Therapeutics (HRTX), DENTSPLY SIRONA (XRAY)
Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $4
Northland Securities Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $9
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (BHVN), Arrowhead Pharmaceuticals (ARWR) and Heron Therapeutics (HRTX)
Heron Therapeutics Price Target Maintained With a $4.00/Share by Needham
Heron Therapeutics Analyst Ratings
Northland Securities Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $9
Heron Therapeutics (HRTX) Gets a Buy From Northland Securities
Heron Therapeutics Analyst Ratings
Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Cuts Target Price to $4
Northland Securities Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $9
Heron Therapeutics Analyst Ratings
Needham Maintains Heron Therapeutics(HRTX.US) With Buy Rating, Maintains Target Price $5
Heron Therapeutics Analyst Ratings
Heron Therapeutics Analyst Ratings
Heron Therapeutics Analyst Ratings